Yahoo Movies
Thatcher Demko signs on the dotted line in Vancouver
Proving his worth as a starter, Thatcher Demko's $25 million extension should pay dividends for the Vancouver Canucks.
Proving his worth as a starter, Thatcher Demko's $25 million extension should pay dividends for the Vancouver Canucks.
Shares of India's top private-sector lender HDFC Bank Ltd fell almost 4% on Monday, dragging the Nifty private-sector bank index down, as investors sold off positions on worries that rising COVID-19 cases would hurt the asset quality of banks. "Due to rising cases, lockdowns have been announced in some parts of the country, and this will have an impact on asset quality of the banks, resulting in higher NPAs," Anita Gandhi, a whole time director at Arihat Capital, said. HDFC Bank over the weekend said its board had approved its proposal to raise 500 billion rupees in the next 12 months through a private placement, and added that the second wave of coronavirus infections, will continue to impact the bank's results.
MSCI's broadest index of Asia-Pacific shares outside Japan went as high as 699.70, a level not seen since March 18. "The extremely supportive monetary and fiscal policy setting continues to provide a fertile environment for risk assets," said Rodrigo Catril, senior forex strategist at National Australia Bank. Australian shares finished unchanged from Friday's close while New Zealand's benchmark index gained 0.6% and South Korea's KOSPI added 0.1%.
She won multiple National Awards for her films
The White Sox and Red Sox begin at 11:05 a.m. at Fenway Park in the annual Patriots’ Day game. The event usually coincides with the Boston Marathon -- in past years, fans in the Green Monster seats would turn around to catch a glimpse of the leaders while others headed over after the final out to cheer on the runners in Kenmore Square, about a mile from the finish line. Chicago ace Lucas Giolito (1-0, 2.55 ERA) is slated to start the series finale against Nathan Eovaldi (2-1, 2.08).
Like many young football players growing up in North Carolina, Chase Rice had his sights set on the NFL. After an outstanding sophomore season with the Tar Heels, that goal seemed realistic. Then the linebacker who tore up the ACC in 2006 tore up his left ankle in the season opener as a junior. Though he returned in 2007, Rice already knew pro football player was not going to be on his resume. Country music star would be. But when draft time approaches, Rice recalls those days on the field, and his hopes of reaching football's highest level. “I certainly felt headed in that direction,” Rice says. "My (2006) year I was the only player who didn’t come off the field, I could play inside and outside, and it was looking good. Then I only got a quarter and a half in my junior year, and that would have been my year and hopefully we were headed for the top of the ACC. “The next year the ankle was not the same, and I wasn’t the same player.” During the 2009 draft, five Tar Heels were selected, including wide receiver Hakeem Nicks to the Giants in the first round. Nicks won a Super Bowl for the 2011 season with New York. Tight end Richard Quinn and wideout Brandon Tate went in the second round; tackle Garrett Reynolds, one of Rice's closest friends today, was selected in Round 5, as was receiver Brooks Foster. “I was up there playing the calibre of football those guys were and that is why I can say I think I was up there to get drafted had I not been injured," Rice says. “Obviously, you've got to get in the games and show up and get your experience. I felt I was right up with those guys and certainly do believe I had the chance. It didn’t work out that way.” It worked out pretty well for Rice in another area of entertainment. His current hit is a pairing with Florida Georgia Line: “Drinkin’ Beer. Talkin’ God. Amen.” Rice also co-wrote the No. 1 song “Cruise” for that duo, which Florida Georgia Line also re-released as a remix featuring Nelly. On his own, Rice has had two top five hits and a double-platinum No. 1 in “Eyes On You.” Some of his songs reflect on his days as an athlete, particularly "Beats A Million Bucks" and “Carolina Can,” which has become something of an anthem for not only Tar Heels fans but the state itself. Rice sought out Scooter Carusoe, who had written several hit songs, for “Carolina Can.” “I knew of him living in Carolina, and 'Anything But Mine' (video) would pop up on TV,” Rice says of the Kenny Chesney megahit. “I dreamed of writing with Scooter. This was the first time I'd ever written that I wanted to write a song about going home, a place very special. He knows a lot about Chapel Hill and Asheville, and we started talking about my history with Carolina. But we didn’t really have a hook. As we're driving to lunch, he looks at me with this smile and just says: 'When I need someone to remind me who I am, Carolina Can.' “It was written in a second after that; we had a purpose of why we write. It's one of my favourites of all time ... I've seen boats named after that, and people scream it at the concert. I played the Azalea Festival in Wilmington and didn’t have to sing one word. I will play in Washington state and they are all singing it. Everybody can relate to it. Every place has their own story.” The story for all musical artists during the COVID-19 pandemic has been the same — trying to get their work out to fans while not being able to play live concerts. Along with headlining his own tours, Rice has opened for Garth Brooks and Chesney — at NFL venues. After performing at a gala for Super Bowl champion coach Bruce Arians' foundation celebrity golf classic on Sunday, Rice can't wait to get back on the road. “On a football field it is different because you are running out with your team,” Rice says. "My band and crew are my team, but always there's that moment I am by myself before I walk onstage. It is an awesome feeling, but it can also be lonely. When you're standing by yourself, it shows the definitive difference of running with a team and running out by yourself. And it is pretty intense. “I was telling one of my buddies in 2017 that it broke my heart I never got a chance to play in the NFL,” Rice recalls, “and he didn’t say anything and I was expecting a response. And then he goes, 'Didn’t you just tell me you played with Kenny Chesney at Lucas Oil Stadium? Is that not an NFL stadium? "That is a perspective right there; dreams in a weird way have absolutely come true.” ___ More AP NFL coverage: https://apnews.com/hub/NFL and https://twitter.com/AP_NFL Barry Wilner, The Associated Press
Phase 2a trial in non-small cell lung cancer expected to begin enrollment in the US in the second half of 2021REHOVOT, Israel, April 19, 2021 (GLOBE NEWSWIRE) -- NeoTX Therapeutics (NeoTX), a clinical-stage immuno-oncology company, announced today that it received clearance from the U.S. Food and Drug Administration (FDA) for the Company’s Investigational New Drug (IND) application for naptumomab estafenatox (NAP). NeoTX is developing targeted anticancer immunotherapies utilizing its proprietary Tumor Targeted Superantigen (TTS) platform. NAP, the company’s lead TTS molecule, binds a genetically engineered bacterial determinant to the tumor surface while simultaneously activating and expanding tumor specific immune cells. NAP has demonstrated preliminary safety and anti-tumor activity in early-stage clinical trials in solid tumors. “This FDA clearance is an exciting milestone for NeoTX,” said Asher Nathan, Ph.D., chief executive officer of NeoTX. “Preclinical and preliminary clinical studies have demonstrated that NAP has potential in combination with other treatment modalities. Non-small cell lung cancer is one of the deadliest cancers, and we are looking forward to assessing NAP in the clinic in combination with chemotherapy as a potential new treatment option after failure of current standards of care.” The Phase 2a open label trial will evaluate NAP in combination with docetaxel in 35 patients with checkpoint inhibitor pretreated, advanced or metastatic non-small cell lung cancer. The primary endpoint is objective response rate as measured by RECIST 1.1 criteria. The trial will also evaluate safety, duration of response, progression free survival, overall survival, pharmacokinetics and pharmacodynamics. About NeoTXNeoTX is a clinical-stage immuno-oncology company which is developing targeted anticancer immunotherapies utilizing its proprietary Tumor Targeted Superantigen (TTS) platform. TTS binds a genetically engineered bacterial determinant to the tumor surface while simultaneously activating and expanding tumor specific immune cells that are then redirected from the periphery to the tumor to mount an effective response. The company’s lead TTS molecule, naptumomab estafenatox (NAP) is currently in clinical development for advanced solid tumors. For more information, please visit www.neotx.com. Media Contact:Cait Williamson, Ph.D.LifeSci Communications(646) 751-4366cait@lifescicomms.com
Valoe Corporation Stock Exchange Release 19 April 2021 at 09.30 Finnish time Valoe Corporation has, pursuant to the terms and conditions of the financing arrangement between Valoe Corporation and Winance announced on 22 April 2020, withdrawn the fourth convertible notes tranche of EUR 500,000 and issued to Winance in total 500 convertible notes and in total 833,333 warrants related thereto. In Mikkeli, 19 April 2021 Valoe Corporation BOARD OF DIRECTORS For more information:CEO Iikka Savisalo, Valoe CorporationTel. +358 405216082email: iikka.savisalo@valoe.com Distribution:Nasdaq Helsinki OyMain mediawww.valoe.com Valoe Corporation specializes in the clean energy, especially in photovoltaic solutions. Valoe provides automated production technology for solar modules based on the company’s own technology; production lines for modules; solar modules and special components for solar modules. Valoe's head office is located in Mikkeli, Finland.
Phase IIa trial in non-small cell lung cancer expected to begin enrollment in the US in the second half of 2021 Lund Sweden, April 19, 2021 - Active Biotech AB (publ) (NASDAQ STOCKHOLM: ACTI) and NeoTX today announced that they have received clearance from the U.S. Food and Drug Administration (FDA) for the Investigational New Drug (IND) application of the tumor targeted superantigen naptumomab estafenatox (Naptumomab). The Phase IIa open label trial will evaluate naptumomab in combination with docetaxel in 35 patients with checkpoint inhibitor pretreated, advanced or metastatic non-small cell lung cancer. The primary endpoint is objective response rate as measured by RECIST 1.1 criteria. The trial will also evaluate safety, duration of response, progression free survival, pharmacokinetics and pharmacodynamics. Naptumomab treatment regimens have demonstrated preliminary safety and anti-tumor activity in early-stage clinical trials in solid tumors. Naptumomab binds a genetically engineered bacterial determinant to the tumor surface while simultaneously activating and expanding tumor specific immune cells. “The FDA clearance of the IND for phase II clinical trial of naptumomab in non-small cell lung cancer marks a significant step in the continuing development of naptumomab as well as our collaboration with NeoTX. We are glad to receive the IND clearance and are excited to follow the progress of the development of naptumomab and the upcoming clinical Phase IIa trial” said Helén Tuvesson, CEO, Active Biotech AB. See also www.neotx.com for NeoTX’s communication related to this information. For further information, please contact: Helén Tuvesson, CEO, +46 46 19 21 56, helen.tuvesson@activebiotech.com Hans Kolam, CFO, +46 46 19 20 44, hans.kolam@activebiotech.com Active Biotech AB (Corp. Reg. No. 556223-9227) Box 724, 220 07 Lund, Sweden +46 46-19 20 00 www.activebiotech.com This information is information that Active Biotech AB is obliged to make public pursuant to the EU Market Abuse Regulation. This information was submitted for publication, through the agency of the contact person set out above, at 08.30 a.m. CET on April 19, 2021. Active Biotech Active Biotech AB (publ) (Nasdaq Stockholm: ACTI) is a biotechnology company that deploys its extensive knowledge base and portfolio of compounds to develop first-in-class immunomodulatory treatments for specialist oncology and immunology indications with a high unmet medical need and significant commercial potential. Following a portfolio refocus, the business model of Active Biotech aims to advance projects to the clinical development phase and then further develop the programs internally or pursue in partnership. Active Biotech currently holds three projects in its portfolio: Naptumomab, a targeted anti-cancer immunotherapy, partnered to NeoTX Therapeutics, is in a Phase I/II clinical program in patients with advanced solid tumors. The small molecule immuno-modulators, tasquinimod and laquinimod, both having a mode of actions that includes modulation of myeloid immune cell function, are targeted towards hematological malignancies and inflammatory eye disorders, respectively. Tasquinimod, is in clinical phase Ib/IIa for treatment of multiple myeloma. Laquinimod is advancing to phase II for treatment of non-infectious uveitis during second half of 2021. Please visit www.activebiotech.com for more information. About NeoTX NeoTX is a clinical-stage immuno-oncology company which is developing targeted anticancer immunotherapies utilizing its proprietary Tumor Targeted Superantigen (TTS) platform. TTS binds a genetically engineered bacterial determinant to the tumor surface while simultaneously activating and expanding tumor specific immune cells that are then redirected from the periphery to the tumor to mount an effective response. The company’s lead TTS molecule, naptumomab estafenatox is currently in clinical development for advanced solid tumors. For more information, please visit www.neotx.com. Naptumomab was licensed from Active Biotech to NeoTX Therapeutics Ltd in 2016. NeoTX is responsible for the global development and commercialization of naptumomab for the treatment of cancer under the license agreement. Attachment 210419_FDA Clearance of IND
April 19th, 2021 Aéroports de Paris SATerms of availability or consultation of the information mentioned in Article R.225-83 of the French Commercial Code, relating to thecombined general meeting of 11 May 2021 Disclaimer: Given the risks linked to the Covid-19 epidemic and in accordance with Order n°2020-321 of 25 March 2020 and Decree n°2020-418 of 10 April 2020, and in particular following Decree n°2021-255 of 9 March 2021 extending until 31 July 2021 the measures for adapting the rules of meeting and deliberation of the assemblies, Aéroports de Paris is unable to physically gather its shareholders. Indeed, the administrative measures limiting or prohibiting travel or collective gatherings for sanitary reasons and the obligation to respect sanitary rules prevent the physical presence at the general meeting of its members. Shareholders are invited to regularly visit the Company's website to consult the documents relating to the general meeting. The Board of Directors has decided that the Combined Annual General Meeting of shareholders will be held in camera, without the physical presence of shareholders and other persons entitled to attend, at the Company's registered office (1, rue de France, 93290 - Tremblay en France), on Tuesday 11 May 2021 at 3:00 p.m., and will be webcasted live and in its entirety on the website https://www.groupeadp.fr (Finance/ General Meeting/ General Meeting 2021 section). A replay will then be available on the Company's website at the same address. The Board of Directors has appointed the French State and Predica, Prévoyance, dialogue du Crédit Agricole as scrutineers. Prior notice of the meeting, including the agenda and the text of the resolutions, was published in the Bulletin des Annonces Légales Obligatoires on 31 March 2021 (Bulletin No. 39). The notice of meeting was published in the Bulletin des Annonces Légales Obligatoires on 19 April 2021 and in the Journal d'Annonces Légales on 19 April 2021. The terms and conditions for participation and voting at this meeting are set out in the latter notice. Due to the fact that this general meeting is being held in camera in the exceptional context of the health crisis, no admission cards will be issued, no amendments to the draft resolutions may be tabled at the meeting and shareholders will only be able to exercise their voting rights remotely and prior to the date of the general meeting. The brochure of the notice of meeting and the information or documents relating to the general meeting, in particular those referred to in Article R.22-10-23 of the French Commercial Code, can be consulted at the following address : http://www.groupeadp.fr (section Finance / General Meeting / General Meeting 2021), in accordance with the applicable legal and regulatory provisions. The documents listed in Article R. 225-83 of the French Commercial Code are posted on the company's website at the above address and kept at the disposal of the shareholders in accordance with the applicable legal and regulatory provisions. Shareholders are invited to regularly consult the section dedicated to the General Meeting on the website http://www.groupeadp.fr to be informed of the latest communications. Investor Relations: Audrey Arnoux, Head of Investor Relations +33 6 61 27 07 39 - invest@adp.fr Press contact: Lola Bourget, Head of Medias and Reputation Department +33 1 74 25 23 23 Groupe ADP develops and manages airports, including Paris-Charles de Gaulle, Paris-Orly and Paris-Le Bourget. In 2020, the group handled through its brand Paris Aéroport 33.1 million passengers and 1.8 million metric tons of freight and mail at Paris-Charles de Gaulle and Paris-Orly, and more than 96.3 million passengers in airports abroad. Boasting an exceptional geographic location and a major catchment area, the group is pursuing its strategy of adapting and modernizing its terminal facilities and upgrading quality of services; the group also intends to develop its retail and real estate businesses. In 2020, group revenue stood at €2,137 million and net result attributable to the Group at -€1,169 million. Registered office: 1, rue de France, 93 290 Tremblay-en-France. Aéroports de Paris is a public limited company (Société Anonyme) with share capital of €296,881,806. Registered in the Bobigny Trade and Company Register under no. 552 016 628. groupeadp.fr Attachment Aéroports de Paris SA - Terms of availability or consultation of the information relating to the combined general meeting of 11 May 2021
By this notice AUGA group, AB (code 126264360, address Konstitucijos ave. 21C, Vilnius, Company) updates the agenda of the ordinary general meeting of shareholders of the Company on 30 April 2021 by drafts of decisions and related information: Management comment: In 2020, audited revenues of AUGA group, AB and its subsidiaries (Group) were EUR 83.07 million (EUR 83.11 million revenues were reported in interim financial statements for 12 months period ended 31 December 2020, hereinafter unaudited data). Audited net profit of the Group for year 2020 was EUR 1.79 million (unaudited net profit of EUR 0.94 million for year 2020 reported earlier). Group's audited EBITDA for the year 2020 amounted to EUR 20.83 million (unaudited EBITDA of EUR 21.07 million for year 2020 reported earlier). Draft decisions of the ordinary shareholders meeting of the Company regarding questions of the Agenda of the Meeting are the following: 1. Consolidated annual report of the Company for the year 2020 and Auditor’s report Taken for the information. 2. Approval of consolidated and separate annual financial statements of the Company for the year 2020 To approve consolidated and separate annual financial statements for the year 2020. 3. Approval of the profit (loss) allocation of the Company for the year 2020 To distribute the Company‘s profit in the total sum of EUR 11,088,936 available for appropriation, as follows: No.RatiosAmount, Euros1. Non-allocated profit (loss) of the previous year at the end of the financial year as of 31 December 2020 6,701,288 2. Net profit (loss) for the financial year 4,140,648 3. Profit (loss) for the reporting financial year not recognized in the profit and loss account - 4. Share based payment for employees’ expenses accounted in the profit and loss account 247,000 5. Shareholders' contribution against losses - 6. Portion of the reserve of tangible fixed assets - 7. Profit (loss) for allocation (1+2+3+4+5+6) 11,088,936 8. Allocation of profit to compulsory reserve 207,032 9. Allocation of profit to reserve for granting of shares 493,000 10. Allocation of profit to other reserves - 11. Allocation of profit to dividends - 12. Allocation of profit to tantièmes - 13. Non-allocated profit (loss) at the end of the reporting year carried forward to next financial year (7-8-9-10-11-12) 10,388,904 4. Appointment of the auditor to audit consolidated financial statements of the Company for the year 2021 and approval of auditor’s remuneration To appoint UAB PricewaterhouseCoopers (code: 111473315) as the Company‘s audit enterprise to perform the audit of the Consolidated and Separate Financial Statements for the 2021 financial year. To authorize the Company‘s General manager to conclude the agreement for audit services, establishing the payment for services as agreed between the parties but in any case, not more than EUR 60,000 (sixty thousand) (VAT excluded) per year for the audit of the Company‘s Consolidated and Separate Financial Statements. 5. Approval of new wording of the Articles of Association of the Company To amend Articles of Association of the Company by: To supplement Article 7.13 of the Articles of Association of the Company with: “The quorum for meetings of the Board shall be calculated from the members of the Board in office”.To supplement Article 7.18 Articles of Association of the Company with: “In case of unpredictable circumstances, the Board has the right to change the date of General Meeting of Shareholders convened by the Board or cancel the General Meeting of Shareholders convened by the Board.”few other amendments to implement best corporate governance practices, as per the draft of new wording of the Articles of Association provided for approval. To approve the new wording of the Articles of Association of the Company as per the attached draft. Authorize and instruct the general manager to have such new wording of the Articles of Association registered with the Register of Legal Persons. 6. Election of the Board To recall members of the Board of the Company on the grounds of the expiry of the term of office of the Board;To elect new members of the Board of the Company: Andrej CybaTomas KrakauskasDalius MisiūnasMurray SteeleMichaela Tod According to the information provided to the Company by the candidates, Andrej Cyba, Dalius Misiūnas, Murray Steele and Michaela Tod are considered to be independent candidates. Information about proposed candidates is attached as annex to this notice. 7. Approval of the remuneration for newly elected members of the board To approve the following remuneration for the newly elected board members for one tenure: EUR 1,900 (before taxes) for members of the Management Board and EUR 2,500 (before taxes) for the chairman of the Management Board per one board meeting, which includes preparation for the meeting, travel time to/from the meeting, attending the meeting, follow-up questions and closure work related to the meeting. Should there be more than 12 board meetings in 12 months, the indicated remuneration is to be paid for each meeting. Should there be less than 12 meetings per 12 consecutive months, board member will nonetheless receive remuneration for 12 meetings per 12 months. Remuneration shall not be paid for the decisions made in writing or any other way in between the meetings nor for meetings which the board member did not attend;For board members living abroad – compensation of travel and accommodation costs for/during attendance of the board meeting – not exceeding EUR 500 + VAT (Lithuanian tariff) in respect to one board meeting in which he/she participated; if the board member participates in a meeting via communication/IT measures (not physically traveling to Lithuania), travel costs compensation shall not be paid for such participation. 8. Provision of the Strategy implementation report. Taken for information. Attached: Independent Auditor’s Report, Consolidated Annual Report and Consolidated and Separate Financial Statements for the Year Ended 31 December 2020.Confirmation of responsible persons.Notice of Explanation of Divergence in the Result of the reporting year in Audited Annual Financial Statements from the published Preliminary results.Comment regarding approval of the profit (loss) allocation.Draft of the new wording of the Articles of Association of the Company.Information about candidates to the Board of the Company.Strategy implementation report.General voting ballot. CEOKęstutis Juščius+370 5 233 5340 Attachments A1_AUGA group Annual Report A2_Confirmation of responsible persons A3_Notice of Explanation of Divergence in the Result A4_Comment regarding approval of the profit (loss) allocation A5_Draft of the new wording of Articles of Association A6_Information about candidates to the Board A7_Strategy implementation report A8_General voting ballot_30042021_VAS
Stockholm, April 19, 2021 – The Board of Directors of Anoto Group AB (publ) (“Anoto” or the “Company”) has appointed a new CEO for the Company. Perry Ha, who previously has served as Chairman of the Board, will assume the role as CEO, when the previous CEO, Joonhee Won, steps down. Joonhee Won will instead be focusing on developing Anoto’s subsidiary for AI based education solutions, Knowledge AI, Inc. As Perry Ha is taking over as CEO, Jörgen Durban has, by the Board of Directors, been appointed as the new Chairman of the Board. “We are pleased to have Perry join Anoto as CEO. He has effectively served on the Board of Anoto for the past four years and is very familiar with Anoto’s business, which will allow for a smooth transition from the company’s previous CEO. Perry is enthusiastic about the future of Anoto, and I am convinced he will be an excellent leader for the company in the years to come,” says Jörgen Durban, Chairman of the Board of Anoto. Perry has an extensive experience in investing in and managing successful technology companies. He lives and works in the US, where he founded Draper Athena, a venture capital firm with offices in in Silicon Valley, Korea and China. He is an alumnus of Massachusetts Institute of Technology (MIT), where he received his bachelor’s and master’s degree. He then earned his MBA at Harvard Business School. Perry is currently serving as a Board member of MIT Corporation, its Board of Trustees and chairs KACF-SF, a non-profit organization in San Francisco. “It is no secret that Anoto has had a hard time finding its commercial position; yet, I can see the company’s opportunities increasing as the world now begins to understand the benefits of its technology. Anoto has a unique technology that seamlessly connects the analogue to digital world without changing the user’s existing behavior, a powerful concept that has a huge commercial potential. I am excited to join the company at this time and believe my background will serve the company well in its growth phase,” says Perry Ha, CEO of Anoto. For further information, please contact: Jörgen Durban, Chairman of the Board, Anoto Group AB For more information about Anoto, please visit www.anoto.com or email ir@anoto.comAnoto Group AB (publ), Reg.No. 556532-3929, Flaggan 1165, SE-116 74 Stockholm This information is information that Anoto Group AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on April 19, 2021 at 08:30 CET. About Anoto Group Anoto is a publicly held Swedish technology company known globally for innovation in the area of information-rich patterns and the optical recognition of those patterns. It is a leader in digital writing and drawing solutions, having historically used its proprietary technology to develop smartpens and related software. These smartpens enrich the daily lives of millions of people around the world. Anoto currently has three main business lines: Livescribe retail, Enterprise Forms and OEM. Anoto also owns Knowledge AI, a leading AI based education solution company, as its majority-controlled subsidiary. Anoto is traded on the Small Cap list of Nasdaq Stockholm under ANOT. Attachment PR_CEO Appointment_FINAL
We speak to a top London hairdresser to find out the benefits and warnings of using lemon juice in your hair.
BERLIN — Germany's environmentalist Greens were set to announce Monday who will make the party's first run for the chancellery in September's national election, while a power struggle in Chancellor Angela Merkel's centre-right bloc entered its second week. The Greens' smooth staging of the announcement of which of their co-leaders, Annalena Baerbock or Robert Habeck, will seek Germany's top job contrasts with the increasingly heated standoff in Merkel's Union bloc. The Sept. 26 parliamentary election is unpredictable, in part because the incumbent isn't seeking re-election. Merkel vowed in 2018 not to seek a fifth four-year term, and no single obvious successor was ready to step up. The governors of Germany's two most populous states, Armin Laschet and Markus Soeder, are battling for the centre-right nomination to succeed her. They missed a self-imposed deadline to agree by Sunday. Recent polls have shown the Greens running second behind the Union and ahead of Germany's traditional big centre-left party, the Social Democrats. Baerbock and Habeck have led the Greens since early 2018. A pragmatic and harmonious duo, they have presided over a rise in poll ratings. The Greens are in opposition nationally but sit in 11 of Germany’s 16 state governments. Recent polls show support for the party of 20-22%, more than twice the 8.9% it won in the 2017 election. Baerbock, 40, has been a lawmaker in the national parliament since 2013 but lacks government experience. Habeck, 51, served for several years as the agriculture and environment minister of the northern state of Schleswig-Holstein. The choice of candidate will need endorsement from a party congress in June. The Greens last month unveiled a program that proposes speeding up Germany’s exit from coal-fired power, raising carbon prices and massively increasing infrastructure spending. They are pro-European Union and take a tough line toward Russia, calling for an end to the Nord Stream 2 gas pipeline project. “For the first time ... the political alternative will be green against black,” the colour of the Union, Green former Environment Minister Juergen Trittin told ZDF television. “The question is: should we make this country fit for the future through climate protection, or do we just want retention of power at any price — the performance the Union is staging now.” Whatever the election outcome, the Greens may hold the key to forming the next government. The traditionally left-leaning and once notoriously chaotic party was the junior partner in centre-left Chancellor Gerhard Schroeder's government from 1998 to 2005. It has become increasingly open to alliances with centre-right parties, and is part of a wide variety of coalitions at state level. Merkel's Union bloc, meanwhile, was still waiting for a candidate on Monday. Laschet, the leader of Merkel’s Christian Democratic Union, and Soeder, the head of its smaller Bavarian sister party, the Christian Social Union, both declared their interest in running for chancellor on April 11. They didn't specify how they would decide their competition. A standoff ensued that many supporters fear could cause lasting damage. Laschet and Soeder are the state governors of North Rhine-Westphalia and Bavaria respectively. Soeder has much better poll ratings, but Laschet is the recently elected leader of by far the bigger of the sister parties. Last Monday, Laschet rallied the CDU leadership behind his bid and called for a quick decision. But Soeder said the matter shouldn’t be resolved “only in a small back room." On Tuesday, the contenders addressed a meeting of the Union bloc’s joint parliamentary group that laid bare divisions in the CDU. Parts of Merkel's party favour Soeder, while others are appalled by his power play for the top job. German media reported that Laschet, Soeder and close aides met late Sunday night, apparently without a result. Shortly before, leaders of the Union's youth wing had come out for Soeder. The Social Democrats, who provided three of Germany's eight post-World War II chancellors but have long been stuck in a poll slump, nominated Finance Minister Olaf Scholz as their candidate for chancellor months ago. Geir Moulson, The Associated Press
This was the second missions for Kate Rubins, and Sergei Ryzhikov Ryzhikov but first mission for Sergei Kud-Sverchkov.
For months last year, Figure Skating in Harlem included no figure skating. Due to the COVID-19 pandemic, the members of the 24-year-old organization that serves young women of color in New York City didn't see the ice from late winter until fall. “We had 7- and 8-year-olds up to 18-year-olds, and I have to say when you are able to move physically it helps you mentally,” says Sharon Cohen, CEO and founder of Figure Skating in Harlem.
According to the Health Minister, so far, only 287 claims have been approved under the PMGKP scheme.
British cyber-security firm Darktrace said on Monday its planned $4 billion premium listing on the London Stock Exchange would take place in early May. Darktrace, backed by tech entrepreneur Mike Lynch, aims to raise new funds to accelerate product development and strengthen its balance sheet. The technology company, founded in 2013 in the university city of Cambridge, uses AI to understand IT networks and detect attacks by identifying unusual behaviour.
SEOUL, South Korea., April 19, 2021 (GLOBE NEWSWIRE) -- As individuals seek advice for weathering the current volatile investing environment, KB Lancaster Securities today announces the launch of a leading-edge AI platform that generates the data and insights they need to better understand their client's needs and enhance portfolio construction. "Record levels of market uncertainty have made it critical for our wealth advisors to have a full, accurate view of our client's assets and offer enhanced investment portfolios. During this volatile time, our clients still expect accurate, insightful advice when they require it, and our new AI platform prepares our wealth managers with a deeper, holistic view of their assets and projected investment opportunities." said William Price who heads up the Corporate Asset Management department at KB Lancaster Securities. The new AI platform uses advanced data analytics along with fully integrated workflows to automate and streamline processes, lower operational costs, and assist with enhanced investment portfolio creation. AI-based techniques utilize machine learning principles to automatically learn from vast networks of data inputs that can be used to forecast asset price movement over a desired period of time. "We serve clients across the globe who all have varying expectations when it comes to investing, by modernizing with AI technology, we will be better able to address those differing needs, solidify those relationships and strengthen our investment portfolios." added Lee Tae-Ho, an Equity Investment Analyst at KB Lancaster Securities. AI extracts important financial signals to provide advisors insight into their clients' current and future financial needs. AI can be used to personalize investment recommendations based on social indicators signalling major life events, like childbirth or retirement. By placing the client at the heart of every investment, powered by leading-edge AI-driven analytics, and delivered with improved personalization, financial managers at KB Lancaster Securities can better understand and interpret the needs of their clients. About KB Lancaster Securities The team at KB Lancaster Securities has continued to expand, our wealth managers and advisory professionals are highly trained, qualified and fluent across multiple languages. Whether your financial goal is to achieve an optimum asset allocation or to invest in value-added investment products, we will customise a wealth planning solution for you to reach your financial objectives throughout the various stages of your life. For more information please visit our website: www.klsholdings.com/ Media Contact Company: KB Lancaster Securities Contact: Mr. Lee Tae-Ho, Equity Investment Analyst Company Email: lee.taeho@klsholdings.com Telephone - +82 2 2023 5850 Address - 16F Gwanghwamun Building, 149 Sejong-daero, Jongro-gu, Seoul, South Korea. 110-730 Website: https://www.klsholdings.com/ SOURCE: KB Lancaster Securities
Shakuntala Bharvani used the lockdown to re-ignite a much deeper connect — that with her lost homeland, which has resulted in a book marked by nostalgia and occasional touches of humour.
The victory keeps the Heat within two games of sixth-place in the Eastern Conference.